169 related articles for article (PubMed ID: 32762529)
21. Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors.
Ashooriha M; Khoshneviszadeh M; Khoshneviszadeh M; Rafiei A; Kardan M; Yazdian-Robati R; Emami S
Eur J Med Chem; 2020 Sep; 201():112480. PubMed ID: 32652434
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis, in Vitro, and in Silico Evaluation of N-Phenylacetamide-Oxindole-Thiosemicarbazide Hybrids as New Potential Tyrosinase Inhibitors.
Yari Boroujeni S; Haghighijoo Z; Mohammadi-Khanaposhtani M; Mosadeghkhah A; Moazzam A; Yavari A; Hajimahmoodi M; Sabourian R; Hosseini S; Larijani B; Hamedifar H; Ansari S; Mahdavi M
Chem Biodivers; 2022 Apr; 19(4):e202100666. PubMed ID: 35156774
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors.
Rezaei M; Mohammadi HT; Mahdavi A; Shourian M; Ghafouri H
Int J Biol Macromol; 2018 Mar; 108():205-213. PubMed ID: 29180052
[TBL] [Abstract][Full Text] [Related]
24. The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-β-phenyl-α, β-unsaturated carbonyl scaffold.
Kim SJ; Yang J; Lee S; Park C; Kang D; Akter J; Ullah S; Kim YJ; Chun P; Moon HR
Bioorg Med Chem; 2018 Aug; 26(14):3882-3889. PubMed ID: 29907470
[TBL] [Abstract][Full Text] [Related]
25. Tyrosinase inhibitory effects of Vinca major and its secondary metabolites: Enzyme kinetics and in silico inhibition model of the metabolites validated by pharmacophore modelling.
Sari S; Barut B; Özel A; Şöhretoğlu D
Bioorg Chem; 2019 Nov; 92():103259. PubMed ID: 31518762
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel hydroxybenzaldehyde-based kojic acid analogues as inhibitors of mushroom tyrosinase.
Xie W; Zhang H; He J; Zhang J; Yu Q; Luo C; Li S
Bioorg Med Chem Lett; 2017 Feb; 27(3):530-532. PubMed ID: 28011217
[TBL] [Abstract][Full Text] [Related]
27. Methoxy-Substituted Tyramine Derivatives Synthesis, Computational Studies and Tyrosinase Inhibitory Kinetics.
Nazir Y; Rafique H; Kausar N; Abbas Q; Ashraf Z; Rachtanapun P; Jantanasakulwong K; Ruksiriwanich W
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922836
[TBL] [Abstract][Full Text] [Related]
28. Structure and inhibition mechanism of some synthetic compounds and phenolic derivatives as tyrosinase inhibitors: review and new insight.
Vaezi M
J Biomol Struct Dyn; 2023 Jul; 41(10):4798-4810. PubMed ID: 35510568
[TBL] [Abstract][Full Text] [Related]
29. Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase.
Ashraf Z; Rafiq M; Seo SY; Kwon KS; Babar MM; Zaidi NU
Eur J Med Chem; 2015 Jun; 98():203-11. PubMed ID: 26025140
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tyrosinase by fumaric acid: Integration of inhibition kinetics with computational docking simulations.
Gou L; Lee J; Yang JM; Park YD; Zhou HM; Zhan Y; Lü ZR
Int J Biol Macromol; 2017 Dec; 105(Pt 3):1663-1669. PubMed ID: 27940340
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory Kinetics of Azachalcones and their Oximes on Mushroom Tyrosinase: A Facile Solid-state Synthesis.
Radhakrishnan SK; Shimmon RG; Conn C; Baker AT
Chem Biodivers; 2016 May; 13(5):531-8. PubMed ID: 27061023
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of ergothioneine inhibition of mushroom tyrosinase.
Liao WC; Wu WH; Tsai PC; Wang HF; Liu YH; Chan CF
Appl Biochem Biotechnol; 2012 Jan; 166(2):259-67. PubMed ID: 22068690
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of Bi-heterocyclic Sulfonamides as Tyrosinase Inhibitors: Lineweaver-Burk Plot Evaluation and Computational Ascriptions.
Abbasi MA; Rehman ZU; Rehman AU; Siddiqui SZ; Nazir M; Hassan M; Raza H; Shah SAA; Seo SY
Acta Chim Slov; 2020 Jun; 67(2):403-414. PubMed ID: 33855544
[TBL] [Abstract][Full Text] [Related]
35. Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors.
Choi J; Jee JG
Int J Mol Sci; 2015 Dec; 16(12):28534-48. PubMed ID: 26633377
[TBL] [Abstract][Full Text] [Related]
36. Phosphonic and Phosphinic Acid Derivatives as Novel Tyrosinase Inhibitors: Kinetic Studies and Molecular Docking.
Wolińska E; Hałdys K; Góra J; Olszewski TK; Boduszek B; Latajka R
Chem Biodivers; 2019 Jul; 16(7):e1900167. PubMed ID: 31145516
[TBL] [Abstract][Full Text] [Related]
37. Identification and molecular mechanism of novel 5-alkenyl-2-benzylaminothiazol-4(5H)-one analogs as anti-melanogenic and antioxidant agents.
Kang MK; Yoon D; Jung HJ; Ullah S; Lee J; Park HS; Kim HJ; Kang D; Park Y; Chun P; Young Chung H; Moon HR
Bioorg Chem; 2023 Nov; 140():106763. PubMed ID: 37566943
[TBL] [Abstract][Full Text] [Related]
38. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities.
Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M
Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and discovery of potential tyrosinase inhibitor of new coumarin-based thiophenyl-pyrazolylthiazole nuclei: In vitro evaluation, cytotoxicity, kinetic, and computational studies.
Hosseini Nasab N; Raza H; Eom YS; Hassan M; Kloczkowski A; Kim SJ
Chem Biol Drug Des; 2023 Jun; 101(6):1262-1272. PubMed ID: 36746678
[TBL] [Abstract][Full Text] [Related]
40. Halogenated aromatic thiosemicarbazones as potent inhibitors of tyrosinase and melanogenesis.
Hałdys K; Goldeman W; Jewgiński M; Wolińska E; Anger-Góra N; Rossowska J; Latajka R
Bioorg Chem; 2020 Jan; 94():103419. PubMed ID: 31761412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
